Literature DB >> 27160817

Long-term effects of oral contraceptives on the prevalence of diabetes in post-menopausal women: 2007-2012 KNHANES.

Sung-Woo Kim1, Jae-Han Jeon2, Won-Kee Lee3, Sungwoo Lee4, Jung-Guk Kim2, In-Kyu Lee2, Keun-Gyu Park5.   

Abstract

There is little information on whether past use of oral contraceptives (OCs) at child-bearing age influences the incidences of diabetes and insulin resistance (IR) after menopause. This study aimed to evaluate the association of past use of OCs with the development of diabetes and IR in post-menopausal women. This cross-sectional study was based on data from the Korea National Health and Nutrition Examination Survey carried out from 2007 to 2012. Of the 50405 participants, 6554 post-menopausal women were included in the analysis. The associations of OC use with the prevalence of diabetes in post-menopausal women were examined using multivariate logistic analysis. In addition, fasting glucose and insulin levels were measured in 3338 nondiabetic post-menopausal women, and the association between IR and OCs was examined by the analysis of covariance. The prevalence of diabetes was significantly higher in post-menopausal participants who had taken OCs for more than 6 months than in those who had never taken OCs. The association remained significant after adjusting for multiple confounding factors (odd ratio 1.379; 95 % CI 1.115-1.707; P = 0.003). The duration of OC use was also positively associated with the prevalence of diabetes. Furthermore, taking OCs for more than 6 months led to a significant increase in fasting insulin levels and HOMA-IR in nondiabetic participants. Past use of OCs for more than 6 months led to a significant increase in the prevalence of diabetes in post-menopausal women, and increased IR in nondiabetic participants. These results suggested that the prolonged use of OCs at reproductive age may be an important risk factor for developing diabetes in post-menopausal women.

Entities:  

Keywords:  Diabetes; Insulin resistance; Oral contraceptive; Post-menopausal women

Mesh:

Substances:

Year:  2016        PMID: 27160817     DOI: 10.1007/s12020-016-0972-z

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  31 in total

1.  The burden and treatment of diabetes in elderly individuals in the u.s.

Authors:  Elizabeth Selvin; Josef Coresh; Frederick L Brancati
Journal:  Diabetes Care       Date:  2006-11       Impact factor: 19.112

2.  National, regional, and global rates and trends in contraceptive prevalence and unmet need for family planning between 1990 and 2015: a systematic and comprehensive analysis.

Authors:  Leontine Alkema; Vladimira Kantorova; Clare Menozzi; Ann Biddlecom
Journal:  Lancet       Date:  2013-03-12       Impact factor: 79.321

3.  Oral contraceptive use and association with glucose, insulin, and diabetes in young adult women: the CARDIA Study. Coronary Artery Risk Development in Young Adults.

Authors:  Catherine Kim; David S Siscovick; Stephen Sidney; Cora E Lewis; Catarina I Kiefe; Thomas D Koepsell
Journal:  Diabetes Care       Date:  2002-06       Impact factor: 19.112

4.  Defining menopause status: creation of a new definition to identify the early changes of the menopausal transition.

Authors:  Clarisa R Gracia; Mary D Sammel; Ellen W Freeman; Hui Lin; Elizabeth Langan; Shiv Kapoor; Deborah B Nelson
Journal:  Menopause       Date:  2005-03       Impact factor: 2.953

5.  Intravenous glucose tolerance after 18 months on progestogen or combination-type oral contraceptive.

Authors:  J A Goldman
Journal:  Isr J Med Sci       Date:  1978-03

6.  A prospective study of oral contraceptives and NIDDM among U.S. women.

Authors:  L Chasan-Taber; W C Willett; M J Stampfer; D J Hunter; G A Colditz; D Spiegelman; J E Manson
Journal:  Diabetes Care       Date:  1997-03       Impact factor: 19.112

7.  Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes: The Northern California Kaiser Permanente Diabetes Registry.

Authors:  A Ferrara; A J Karter; L M Ackerson; J Y Liu; J V Selby
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

8.  Parity and incidence of non-insulin-dependent diabetes mellitus.

Authors:  J E Manson; E B Rimm; G A Colditz; M J Stampfer; W C Willett; R A Arky; B Rosner; C H Hennekens; F E Speizer
Journal:  Am J Med       Date:  1992-07       Impact factor: 4.965

9.  Diabetes and modifiable risk factors for cardiovascular disease: the prospective Million Women Study.

Authors:  Elizabeth A Spencer; Kirstin L Pirie; Richard J Stevens; Valerie Beral; Anna Brown; Bette Liu; Jane Green; Gillian K Reeves
Journal:  Eur J Epidemiol       Date:  2008-11-18       Impact factor: 8.082

10.  Impact of age at first childbirth on glucose tolerance status in postmenopausal women: the 2008-2011 Korean National Health and Nutrition Examination Survey.

Authors:  Jin Hwa Kim; Yun Jung; Sang Yong Kim; Hak Yeon Bae
Journal:  Diabetes Care       Date:  2013-11-15       Impact factor: 19.112

View more
  3 in total

1.  Associations of Menstrual Cycle Characteristics Across the Reproductive Life Span and Lifestyle Factors With Risk of Type 2 Diabetes.

Authors:  Yi-Xin Wang; Zhilei Shan; Mariel Arvizu; An Pan; JoAnn E Manson; Stacey A Missmer; Qi Sun; Jorge E Chavarro
Journal:  JAMA Netw Open       Date:  2020-12-01

Review 2.  Efficacy of Treatments for Polycystic Ovarian Syndrome Management in Adolescents.

Authors:  Reem A Al Khalifah; Ivan D Florez; Michael J Zoratti; Brittany Dennis; Lehana Thabane; Ereny Bassilious
Journal:  J Endocr Soc       Date:  2020-10-17

3.  Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study.

Authors:  Balachandran Kumarendran; Michael W O'Reilly; Anuradhaa Subramanian; Dana Šumilo; Konstantinos Toulis; Krishna M Gokhale; Chandrika N Wijeratne; Arri Coomarasamy; Abd A Tahrani; Laurent Azoulay; Wiebke Arlt; Krishnarajah Nirantharakumar
Journal:  Diabetes Care       Date:  2021-10-14       Impact factor: 19.112

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.